NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

TerminatedPhase 2

Sponsor: Pfizer

Conditions: Focal Segmental Glomerulosclerosis (FSGS)

Interventions: PF-06730512

Countries: United States, Canada, Czechia, France, Germany, Italy, Japan, Mexico

The purpose of this Phase 2 adaptive study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of PF-06730512 following multiple intravenous infusions in adult subjects with FSGS.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

1. Adults age 18 years and older who have a confirmed biopsy diagnosis of FSGS.
2. Estimated glomerular filtration rate (eGFR) greater than or equal to 45 ml/min/1.73 m2. If eGFR is 30 - 45 ml/min/1.73 m2, a recent biopsy (within 12 months prior to Screening) must demonstrate \< 50% tubulointerstitial fibrosis.
3. Urine protein:creatinine ratio (UPCR) greater than 1.5 g/g at screening.
4. Treated with at least one but not more than 3 classes of immunosuppressants either alone or in combination, or has a contraindication to use of an immunosuppressant or is intolerant to an immunosuppressant per investigator judgment.

Exclusion Criteria:

1. Diagnosis of collapsing FSGS.
2. Advanced chronic changes on renal biopsy as evidenced by greater than 50% tubulointerstitial fibrosis.
3. Organ transplant.
4. History of malignancy, with the exception of basal or squamous cell carcinoma that has been treated and fully resolved for a minimum of 5 years.
5. Body mass index (BMI) greater than 45 kg/m2.
6. Subjects with a history of prior treatment with or use of interferon, lithium, pamidronate, mTOR inhibitors (eg, sirolimus), testosterone/anabolic steroids, anthracycline (eg, doxorubicin), heroin.

Locations (110)

Birmingham, Alabama, United States
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Los Angeles, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Palo Alto, California, United States
Palo Alto, California, United States
San Francisco, California, United States
Stanford, California, United States
Stanford, California, United States
Stanford, California, United States
New Haven, Connecticut, United States
New Haven, Connecticut, United States
New Haven, Connecticut, United States
New Haven, Connecticut, United States
New Haven, Connecticut, United States
New Haven, Connecticut, United States
Miami, Florida, United States
Miami, Florida, United States
Miami, Florida, United States
Lawrenceville, Georgia, United States
Lawrenceville, Georgia, United States
Iowa City, Iowa, United States
Lenexa, Kansas, United States
+ 80 more on CT.gov